Bill
H 5350
Creates a unified, equity-focused cannabis regime with a new Cannabis Control Commission, license caps, social equity ownership paths, stronger testing, and ongoing reviews.
Purpose and overall intent
- Modernizes and reorganizes Massachusetts cannabis law regime, consolidating and expanding the framework governing both adult-use and medical marijuana. The act is designated as an emergency measure to promptly implement changes intended to improve public health, safety, equity, and regulatory oversight.
Key provisions and changes
1) Creation and governance of a unified Cannabis Control Commission
- Establishes a Massachusetts Cannabis Control Commission (3 commissioners appointed by the governor; one designated as chair). Commissioners must have experience in public health, public safety, social justice, consumer regulation, or the cultivation/distribution of marijuana; at least one commissioner must have a social justice background.
- Strong integrity and ethics requirements: background checks; prohibition on felons serving; residency within MA; prohibitions on holding elected or certain appointed offices; strict conflict-of-interest rules and gifts ban.
- Commission operations: two commissioners constitute a quorum; majority approval required; chair has supervisory authority; Executive Director appointed by the chair with hiring powers, subject to the commission’s policies.
- Ethics and compliance: enhanced ethics code for commissioners/employees, stricter than state law; prohibitions on gifts from licensees/applicants; enforcement and recusal provisions for conflicts.
2) Licensing framework and ownership controls
- Creates licensing caps and ownership rules for retailers, product manufacturers, cultivators, and fully integrated medical marijuana treatment centers, with aggregated limits on how many licenses a single licensee may hold (e.g., up to 6 retailer licenses, 3 fully integrated centers, 3 manufacturers, 3 cultivators), with adjustments when holding multiple license types.
- Introduces a delinquency and vigilance regime: a structured system for credit/indebtedness reporting among licensees, a public delinquent list, and penalties (up to $5,000 per violation) for failing to discharge debts.
- Establishes an orderly transfer mechanism for ownership/control, including protections for creditors and a process to prevent transfers while delinquencies exist.
3) Rebranding and license category updates
- Replaces terminology for medical marijuana treatment centers with “medical marijuana establishment” across multiple statutes and definitions.
- Expands certain license types (e.g., new categories to support limited cultivation, processing, or on-site consumption in particular settings; delivery licenses), with municipal waivers and time-bound flexibility for delivery in municipalities.
4) Social equity, communities, and economic empowerment
- Expands and codifies social equity program criteria; emphasizes participation by communities disproportionately harmed by past cannabis enforcement.
- Requires guidance and best practices for host community agreements, with a focus on social equity businesses and economic empowerment applicants.
- Creates pathways for ownership by social equity or minority/women/veteran-owned enterprises, including exclusivity windows for certain medical marijuana licenses to social equity entities.
5) Regulation, testing, and consumer safeguards
- Updates definitions for testing laboratories and independent testing requirements; strengthens testing accreditation standards.
- Mandates ongoing regulatory review every two years, with public hearings and online, machine-readable reporting of findings.
- Calls for a joint study on cannabis supply, licensing balance, market trends, access to capital, and regulatory adequacy.
6) Tax, market data, and hip-to-date governance
- Requires studies on excise tax impact, market sustainability, and the broader regulatory environment; periodic regulation reviews to align with evolving standards.
- Transfers and consolidations of certain regulatory functions from the former cannabis commission to the new structure; authorizes transfers of personnel and continuity of contracts.
7) Timing and effective date
- Several provisions become effective at different phases; final compliance and implementation actions are tied to a defined schedule, with key regulatory updates required within one year and governance changes phased in by mid-2027-2028.
- Notably, the act specifies an effective date for certain governance reforms and a staggered transition of commissioners.
Impact and who is affected
- Licensees and applicants across medical and adult-use cannabis sectors (retailers, cultivators, product manufacturers, and medical marijuana establishments) will experience new caps, ownership rules, and reporting requirements.
- Municipalities and host communities will face updated processes for host community agreements and social equity incorporation.
- Consumers gain enhanced testing standards, more explicit consumer safeguards, and potential on-site consumption and delivery options in some contexts.
- State agencies oversee a streamlined, equity-centered regulatory regime with ongoing reporting and studies to inform future policy.
Note: This summary captures the bill’s central goals and provisions as filed and amended; for precise statutory language and transitional details, refer to the bill text and accompanying regulatory sections.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
